Recently added

Now showing items 1671-1680 of 75678

Clinical risk prediction model for 30-day all-cause re-hospitalisation or mortality in patients hospitalised with heart failure

Driscoll, A.; Romaniuk, H.; Dinh, D.; Amerena, J.; Brennan, A.; Hare, D.L.; Kaye, D.; Lefkovits, J.; Lockwood, S.; Neil, C.; Prior, D.; Reid, Christopher ; Orellana, L. (2022)

Background: This study aimed to develop a risk prediction model (AUS-HF model) for 30-day all-cause re-hospitalisation or death among patients admitted with acute heart failure (HF) to inform follow-up after hospitalisation. ...
Management of Acute Decompensated Heart Failure in Rural Versus Metropolitan Settings: An Australian Experience

Chan, R.K.; Dinh, D.T.; Hare, D.L.; Lockwood, S.; Neil, C.; Prior, David; Brennan, A.; Lefkovits, J.; Carruthers, H.; Reid, Christopher ; Driscoll, A. (2022)

Background: Acute decompensated heart failure (ADHF) is the most common cause of hospital admission in patients over 65, with poorer outcomes demonstrated in rural versus metropolitan areas. The aim of this study was to ...
The effect of taking blood pressure lowering medication at night on cardiovascular disease risk. A systematic review

Ho, Chau L.B. ; Chowdhury, Enayet ; Doust, J.; Nelson, M.R.; Reid, Christopher (2021)

To investigate the effect of night-time BP-lowering drug treatment on the risk of major CVD and mortality, we systematically reviewed randomized controlled trials comparing night-time versus morning dosing. Two studies ...
Machine Learning Algorithms for Predicting and Risk Profiling of Cardiac Surgery-Associated Acute Kidney Injury

Penny-Dimri, J.C.; Bergmeir, C.; Reid, Christopher ; Williams-Spence, J.; Cochrane, A.D.; Smith, J.A. (2021)

Using a large national database of cardiac surgical procedures, we applied machine learning (ML) to risk stratification and profiling for cardiac surgery-associated acute kidney injury. We compared performance of ML to ...
Comparison of Long-Term Outcomes After Percutaneous Coronary Intervention in Patients With Insulin-Treated Versus Non-Insulin Treated Diabetes Mellitus

Biswas, S.; Dinh, D.; Andrianopoulos, N.; Lefkovits, J.; Ajani, A.; Duffy, S.J.; Chan, W.; Walton, A.; Brennan, A.; Clark, D.J.; Hiew, C.; Oqueli, E.; Reid, Christopher ; Stub, D.; Eccleston, D. (2021)

There are conflicting data on whether patients with insulin-treated diabetes mellitus (ITDM) have poorer outcomes compared with non-insulin treated diabetic (non-ITDM) patients following percutaneous coronary intervention ...
The Impact of Out-of-Hours Presentation on Clinical Outcomes in ST-Elevation Myocardial Infarction

Biswas, S.; Brennan, A.; Duffy, S.J.; Andrianopoulos, N.; Chan, W.; Walton, A.; Noaman, S.; Shaw, J.A.; Ajani, A.; Clark, D.J.; Freeman, M.; Hiew, C.; Oqueli, E.; Lefkovits, J.; Reid, Christopher ; Stub, D. (2020)

Background: Systems of care have been established to ensure patients with ST-elevation myocardial infarction (STEMI) get timely access to primary percutaneous coronary intervention (PPCI). In this study, we evaluated ...
Regional differences in percutaneous coronary intervention outcomes in STEMI patients with diabetes: The Asia-Pacific evaluation of cardiovascular therapies (ASPECT) collaboration

Wong, M.Y.Z.; Yap, J.J.L.; Chih, Hui Jun ; Yan, B.P.Y.; Fong, A.Y.Y.; Beltrame, J.F.; Wijaya, I.P.; Nguyen, H.T.T.; Brennan, A.L.; Reid, Christopher ; Yeo, K.K. (2023)

Background: Diabetes is associated with poorer outcomes and increased complication rates in STEMI patients undergoing percutaneous coronary intervention (PCI). Data are notably lacking in the Asia-Pacific region. We report ...
Trends and Real-World Safety of Patients Undergoing Percutaneous Coronary Intervention for Symptomatic Stable Ischaemic Heart Disease in Australia

Hamilton, G.W.; Yeoh, J.; Dinh, D.; Reid, Christopher ; Yudi, M.B.; Freeman, M.; Brennan, A.; Stub, D.; Oqueli, E.; Sebastian, M.; Duffy, S.J.; Horrigan, M.; Farouque, O.; Ajani, A.; Clark, D.J. (2022)

Background: Percutaneous coronary intervention (PCI) in stable ischaemic heart disease (SIHD) has not been shown to improve prognosis but can alleviate symptoms and improve quality of life. Appropriately selected patients ...
Willingness to be tested for a secondary cause of hypertension: a survey of the Australian general community

Lai, J.H.; Gwini, S.M.; Chen, G.; Long, K.M.; Russell, G.; Schlaich, M.P.; Stowasser, M.; Young, M.J.; Fuller, P.J.; Mori, T.A.; Wolley, M.; Reid, Christopher ; Yang, J. (2022)

Background: Primary aldosteronism (PA) represents the most common and potentially curable cause of secondary hypertension. However, PA is not commonly screened for, and up to 34% of patients who screen positive do not ...
Outcomes of thrombus aspiration during primary percutaneous coronary intervention for ST-elevation myocardial infarction

Rajakariar, K.; Andrianopoulos, N.; Gayed, D.; Liang, D.; Backhouse, B.; Ajani, A.E.; Duffy, S.J.; Brennan, A.; Roberts, L.; Reid, Christopher ; Oqueli, E.; Clark, D.; Freeman, M. (2023)

Background: Previous large multi-centre randomised controlled trials have not provided clear benefit with routine intracoronary thrombus aspiration (TA) as an adjunct to primary percutaneous coronary intervention (PCI) ...

espace - Curtin’s institutional repository

espace: Recent submissions